ciclopirox_PC3_UP
GeneID | Mean_1 | Mean_2 | StDev_1 | StDev_2 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 157574 | 8.7 | 8.8 | 0.2 | 0.0 | 0.629 | 0.5921 | FBXO16 | F-box protein 16 |
2 | 22856 | 12.2 | 12.2 | 0.1 | 0.0 | -1.087 | 0.3839 | CHSY1 | chondroitin sulfate synthase 1 |
3 | 8974 | 7.9 | 9.5 | 0.3 | 0.1 | 7.899 | 0.0136 | P4HA2 | prolyl 4-hydroxylase, alpha polypeptide II |
4 | 123 | 4.1 | 5.2 | 0.1 | 0.9 | 2.016 | 0.1794 | PLIN2 | perilipin 2 |
5 | 23764 | 4.1 | 5.1 | 0.8 | 0.2 | 2.247 | 0.1414 | MAFF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
6 | 8553 | 8.8 | 8.7 | 0.1 | 0.8 | -0.307 | 0.7863 | BHLHE40 | basic helix-loop-helix family, member e40 |
7 | 4616 | 10.6 | 12.8 | 0.2 | 0.7 | 5.320 | 0.0250 | GADD45B | growth arrest and DNA-damage-inducible, beta |
8 | 55603 | 9.3 | 10.0 | 0.1 | 0.1 | 8.922 | 0.0043 | FAM46A | family with sequence similarity 46, member A |
9 | 54435 | 4.6 | 5.1 | 0.6 | 0.5 | 1.160 | 0.3130 | HCG4 | HLA complex group 4 (non-protein coding) |
10 | 54541 | 13.1 | 13.8 | 0.7 | 1.0 | 0.998 | 0.3785 | DDIT4 | DNA-damage-inducible transcript 4 |
11 | 3099 | 7.4 | 7.0 | 0.2 | 0.2 | -2.500 | 0.0747 | HK2 | hexokinase 2 |
12 | 6676 | 7.8 | 6.9 | 0.2 | 0.6 | -2.463 | 0.1095 | SPAG4 | sperm associated antigen 4 |
13 | 51428 | 11.7 | 11.9 | 0.2 | 0.0 | 1.694 | 0.2252 | DDX41 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 |
14 | 2887 | 8.6 | 11.3 | 0.3 | 1.0 | 4.397 | 0.0361 | GRB10 | growth factor receptor-bound protein 10 |
15 | 6513 | 12.6 | 12.7 | 0.3 | 0.5 | 0.270 | 0.8028 | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
16 | 51129 | 8.8 | 8.2 | 0.8 | 0.2 | -1.327 | 0.3044 | ANGPTL4 | angiopoietin-like 4 |
17 | 59339 | 11.3 | 9.3 | 0.1 | 0.7 | -4.711 | 0.0408 | PLEKHA2 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 |
18 | 3576 | 2.3 | 2.2 | 0.0 | 0.0 | -1.311 | 0.2687 | CXCL8 | chemokine (C-X-C motif) ligand 8 |
19 | 6781 | 2.6 | 3.1 | 0.2 | 0.6 | 1.120 | 0.3558 | STC1 | stanniocalcin 1 |
20 | 8614 | 9.4 | 8.9 | 0.6 | 0.9 | -0.811 | 0.4687 | STC2 | stanniocalcin 2 |
21 | 5325 | 6.3 | 5.2 | 0.2 | 0.4 | -4.772 | 0.0202 | PLAGL1 | pleiomorphic adenoma gene-like 1 |
22 | 10957 | 12.0 | 10.4 | 0.0 | 0.7 | -3.893 | 0.0598 | PNRC1 | proline-rich nuclear receptor coactivator 1 |
23 | 1026 | 6.4 | 6.9 | 0.4 | 0.4 | 1.405 | 0.2338 | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
24 | 9770 | 2.8 | 4.3 | 0.4 | 1.0 | 2.485 | 0.0988 | RASSF2 | Ras association (RalGDS/AF-6) domain family member 2 |
25 | 22890 | 7.5 | 8.1 | 0.1 | 0.3 | 4.053 | 0.0292 | ZBTB1 | zinc finger and BTB domain containing 1 |
26 | 6016 | 8.6 | 8.3 | 0.3 | 0.2 | -1.449 | 0.2356 | RIT1 | Ras-like without CAAX 1 |
27 | 79400 | 5.0 | 5.2 | 0.6 | 0.2 | 0.709 | 0.5419 | NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 |
28 | 101 | 11.3 | 10.0 | 0.1 | 0.1 | -18.089 | 0.0002 | ADAM8 | ADAM metallopeptidase domain 8 |
29 | 10397 | 10.8 | 10.2 | 0.1 | 0.1 | -8.146 | 0.0014 | NDRG1 | N-myc downstream regulated 1 |
30 | 10144 | 3.4 | 4.1 | 0.8 | 0.5 | 1.225 | 0.2999 | FAM13A | family with sequence similarity 13, member A |
31 | 9134 | 7.6 | 6.1 | 0.3 | 1.7 | -1.469 | 0.2731 | CCNE2 | cyclin E2 |
32 | 26118 | 10.6 | 11.1 | 0.4 | 0.8 | 0.960 | 0.4113 | WSB1 | WD repeat and SOCS box containing 1 |
33 | 9518 | 12.5 | 13.3 | 1.1 | 1.1 | 0.891 | 0.4234 | GDF15 | growth differentiation factor 15 |
34 | 55076 | 5.7 | 4.5 | 0.2 | 0.2 | -6.808 | 0.0038 | TMEM45A | transmembrane protein 45A |
35 | 8572 | 2.2 | 2.2 | 0.0 | 0.0 | 0.411 | 0.7064 | PDLIM4 | PDZ and LIM domain 4 |
36 | 2049 | 7.6 | 8.8 | 0.4 | 0.7 | 2.415 | 0.0860 | EPHB3 | EPH receptor B3 |
37 | 10570 | 8.9 | 8.8 | 0.1 | 0.2 | -0.803 | 0.4754 | DPYSL4 | dihydropyrimidinase-like 4 |
38 | 64236 | 4.5 | 4.7 | 0.1 | 0.3 | 0.641 | 0.5672 | PDLIM2 | PDZ and LIM domain 2 (mystique) |
39 | 2997 | 11.0 | 10.3 | 0.0 | 0.4 | -3.043 | 0.0900 | GYS1 | glycogen synthase 1 (muscle) |
40 | 3486 | 6.3 | 4.3 | 0.8 | 0.5 | -3.941 | 0.0256 | IGFBP3 | insulin-like growth factor binding protein 3 |
41 | 51141 | 8.0 | 7.5 | 0.3 | 0.5 | -1.570 | 0.2117 | INSIG2 | insulin induced gene 2 |
42 | 3708 | 9.6 | 5.6 | 0.1 | 0.2 | -32.333 | 0.0002 | ITPR1 | inositol 1,4,5-trisphosphate receptor, type 1 |
43 | 54583 | 10.1 | 9.8 | 0.2 | 0.1 | -3.107 | 0.0415 | EGLN1 | egl-9 family hypoxia-inducible factor 1 |
44 | 79094 | 5.2 | 9.4 | 1.8 | 1.2 | 3.408 | 0.0346 | CHAC1 | ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
45 | 384 | 8.4 | 8.2 | 0.2 | 0.3 | -0.970 | 0.3964 | ARG2 | arginase 2 |
46 | 55321 | 2.6 | 3.0 | 0.3 | 0.4 | 1.271 | 0.2782 | TMEM74B | transmembrane protein 74B |
47 | 114088 | 2.8 | 2.5 | 0.2 | 0.2 | -1.425 | 0.2347 | TRIM9 | tripartite motif containing 9 |
48 | 7422 | 8.5 | 10.7 | 0.5 | 1.5 | 2.370 | 0.1188 | VEGFA | vascular endothelial growth factor A |
49 | 55818 | 6.9 | 7.0 | 0.3 | 0.2 | 0.549 | 0.6142 | KDM3A | lysine (K)-specific demethylase 3A |
50 | 5526 | 7.1 | 6.9 | 0.3 | 0.1 | -1.189 | 0.3288 | PPP2R5B | protein phosphatase 2, regulatory subunit B', beta |
51 | 901 | 6.3 | 5.7 | 0.7 | 0.3 | -1.514 | 0.2416 | CCNG2 | cyclin G2 |
52 | 23034 | 6.6 | 5.7 | 0.2 | 0.4 | -3.199 | 0.0436 | SAMD4A | sterile alpha motif domain containing 4A |
53 | 9052 | 8.3 | 7.0 | 0.4 | 1.0 | -2.040 | 0.1498 | GPRC5A | G protein-coupled receptor, class C, group 5, member A |
54 | 694 | 10.6 | 9.8 | 0.1 | 0.6 | -2.225 | 0.1537 | BTG1 | B-cell translocation gene 1, anti-proliferative |
55 | 5806 | 2.4 | 3.4 | 0.0 | 1.0 | 1.800 | 0.2133 | PTX3 | pentraxin 3, long |
56 | 79644 | 7.1 | 7.4 | 0.0 | 0.4 | 1.539 | 0.2604 | SRD5A3 | steroid 5 alpha-reductase 3 |
57 | 10370 | 9.9 | 8.8 | 0.1 | 0.5 | -3.536 | 0.0579 | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
58 | 28231 | 9.3 | 9.3 | 0.2 | 0.9 | -0.008 | 0.9942 | SLCO4A1 | solute carrier organic anion transporter family, member 4A1 |
59 | 11067 | 3.5 | 3.0 | 0.2 | 0.5 | -1.608 | 0.2277 | C10orf10 | chromosome 10 open reading frame 10 |
60 | 79656 | 2.3 | 2.4 | 0.0 | 0.1 | 0.867 | 0.4570 | BEND5 | BEN domain containing 5 |
61 | 665 | 11.9 | 11.0 | 0.1 | 0.3 | -5.232 | 0.0120 | BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like |
62 | 54455 | 9.7 | 10.0 | 0.1 | 0.0 | 5.327 | 0.0262 | FBXO42 | F-box protein 42 |
63 | 1944 | 6.5 | 6.2 | 0.5 | 0.7 | -0.579 | 0.5959 | EFNA3 | ephrin-A3 |
64 | 2026 | 7.4 | 8.3 | 0.1 | 0.7 | 2.281 | 0.1450 | ENO2 | enolase 2 (gamma, neuronal) |
65 | 1837 | 7.5 | 7.8 | 0.1 | 0.2 | 1.628 | 0.1914 | DTNA | dystrobrevin, alpha |
66 | 11237 | 7.9 | 8.8 | 0.4 | 0.1 | 4.196 | 0.0313 | RNF24 | ring finger protein 24 |
67 | 133 | 11.4 | 8.2 | 0.1 | 0.3 | -19.930 | 0.0016 | ADM | adrenomedullin |
68 | 29015 | 2.9 | 2.7 | 0.2 | 0.5 | -0.675 | 0.5502 | SLC43A3 | solute carrier family 43, member 3 |
69 | 8996 | 12.9 | 12.4 | 0.0 | 0.2 | -4.597 | 0.0412 | NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
70 | 55139 | 8.6 | 8.1 | 0.2 | 0.3 | -2.241 | 0.0970 | ANKZF1 | ankyrin repeat and zinc finger domain containing 1 |
71 | 1843 | 8.0 | 8.9 | 0.2 | 0.7 | 2.183 | 0.1388 | DUSP1 | dual specificity phosphatase 1 |
72 | 205 | 11.6 | 11.1 | 0.1 | 0.1 | -5.589 | 0.0130 | AK4 | adenylate kinase 4 |
73 | 9063 | 8.8 | 9.0 | 0.3 | 0.2 | 0.852 | 0.4449 | PIAS2 | protein inhibitor of activated STAT, 2 |
74 | 5209 | 7.4 | 7.5 | 0.1 | 0.1 | 1.453 | 0.2263 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
75 | 29923 | 13.6 | 13.2 | 0.2 | 0.3 | -2.071 | 0.1177 | HILPDA | hypoxia inducible lipid droplet-associated |
76 | 1999 | 10.5 | 10.9 | 0.1 | 1.1 | 0.582 | 0.6186 | ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
77 | 8497 | 4.9 | 5.8 | 0.4 | 0.2 | 3.479 | 0.0344 | PPFIA4 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
78 | 638 | 9.1 | 8.8 | 0.2 | 0.3 | -1.239 | 0.2916 | BIK | BCL2-interacting killer (apoptosis-inducing) |
79 | 5352 | 10.8 | 10.4 | 0.2 | 0.3 | -2.055 | 0.1206 | PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
80 | 23030 | 8.6 | 9.4 | 0.1 | 0.2 | 6.722 | 0.0093 | KDM4B | lysine (K)-specific demethylase 4B |
81 | 9314 | 6.3 | 8.8 | 0.1 | 0.1 | 25.802 | 0.0000 | KLF4 | Kruppel-like factor 4 (gut) |
82 | 7852 | 10.1 | 7.0 | 0.6 | 1.9 | -2.628 | 0.1000 | CXCR4 | chemokine (C-X-C motif) receptor 4 |
83 | 5154 | 6.2 | 7.6 | 0.3 | 0.3 | 5.295 | 0.0061 | PDGFA | platelet-derived growth factor alpha polypeptide |
84 | 5155 | 7.8 | 8.3 | 0.1 | 0.2 | 3.532 | 0.0285 | PDGFB | platelet-derived growth factor beta polypeptide |
85 | 3691 | 12.5 | 11.5 | 0.0 | 0.1 | -12.158 | 0.0048 | ITGB4 | integrin, beta 4 |
86 | 771 | 10.5 | 9.9 | 0.3 | 0.5 | -1.909 | 0.1353 | CA12 | carbonic anhydrase XII |
87 | 2745 | 8.0 | 7.7 | 0.1 | 0.7 | -0.750 | 0.5285 | GLRX | glutaredoxin (thioltransferase) |
88 | 230 | 8.5 | 9.3 | 0.3 | 0.5 | 2.374 | 0.0964 | ALDOC | aldolase C, fructose-bisphosphate |
89 | 55647 | 5.9 | 5.2 | 0.3 | 0.5 | -2.323 | 0.1009 | RAB20 | RAB20, member RAS oncogene family |
90 | 768 | 2.8 | 2.8 | 0.1 | 0.3 | -0.396 | 0.7282 | CA9 | carbonic anhydrase IX |
91 | 4601 | 9.9 | 9.0 | 0.4 | 0.7 | -1.885 | 0.1591 | MXI1 | MAX interactor 1, dimerization protein |
92 | 9123 | 11.2 | 8.6 | 0.2 | 0.7 | -6.278 | 0.0168 | SLC16A3 | solute carrier family 16 (monocarboxylate transporter), member 3 |
93 | 5210 | 7.1 | 7.1 | 0.4 | 1.1 | -0.089 | 0.9359 | PFKFB4 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
94 | 57007 | 14.2 | 8.2 | 0.1 | 0.0 | -130.531 | 0.0000 | ACKR3 | atypical chemokine receptor 3 |
95 | 5163 | 9.3 | 9.1 | 0.3 | 0.5 | -0.590 | 0.5936 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 |
96 | 55279 | 7.7 | 7.2 | 0.3 | 0.3 | -1.976 | 0.1225 | ZNF654 | zinc finger protein 654 |
97 | 55893 | 12.0 | 11.2 | 0.2 | 0.2 | -5.046 | 0.0079 | ZNF395 | zinc finger protein 395 |
98 | 467 | 6.5 | 7.7 | 0.2 | 0.9 | 2.324 | 0.1342 | ATF3 | activating transcription factor 3 |